ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 649

Potentially Reversible Associations with Fatigue in SLE Patients – Results from a Single-centre Study

Christina Duesing1, Gamal Chehab 2, Jutta Richter 3, Oliver Sander 4, Rebecca Fischer-Betz 5, Benedikt Ostendorf 1, Hasan Acar 1, Ralph Brinks 6 and Matthias Schneider 5, 1Policlinic of Rheumatology and Hiller Research Unit Rheumatology, Heinrich-Heine-University, Duesseldorf, Germany, Duesseldorf, Nordrhein-Westfalen, Germany, 2Policlinic of Rheumatology and Hiller Research Unit Rheumatology, Heinrich-Heine-University, Duesseldorf, Germany, 3Department and Hiller Research Unit of Rheumatology, Heinrich-Heine University Duesseldorf, Duesseldorf, Nordrhein-Westfalen, Germany, 4Department and Hiller Research Unit of Rheumatology, Heinrich-Heine University Duesseldorf, Duesseldorf, 5Policlinic for Rheumatology & Hiller Research Centre for Rheumatology, Heinrich-Heine-University Duesseldorf, Düsseldorf, Germany, 6Policlinic for Rheumatology & Hiller Research Centre for Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: depression, Fatigue, quality of life and patient outcomes, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: SLE – Clinical Poster I: Epidemiology & Pathogenesis

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Fatigue is the most common symptom in SLE patients with a strong impact on patients’ reported quality of life. The cause of fatigue is most likely multifactorial. Previous studies identified possible associations with fatigue with some contradictory results. The aim of this study was to identify additional potentially reversible associations with fatigue to generate a target for future interventions.

Methods: Our study population consisted of 234 consecutively recruited SLE (according to the 1997 ACR criteria) outpatients from our university hospital based lupus reference centre. We analyzed clinical and demographic data from routine visits, laboratory variables, as well as sleeping disorders, disease perception, coping, social activities and health locus of control using validated questionnaires. We captured fatigue using the Fatigue Severity Scale (FSS). A score of ≥ 4 points is considered pathological. To assess depression, we used the German CES-D depression scale (values ≥ 23/60 points are considered pathological).

Results: Our predominantly Caucasian cohort (99.1%) was mostly female (87.6%), with a mean age of 45.3 years (±13.4 [SD]) and a mean disease duration of 16.2 years (±9.5). In our cohort, 50.9% of patients reached a pathological result in the FSS. Depression was significantly associated with fatigue (p < 0.001), with 37.5% of patients with fatigue vs. 18.2 % in patients without fatigue showing a clinically relevant CES-D score (mean CES-D score 20.2±9.4 vs. 14.3±8.6). Patients with poor self-assessment of their health condition (including sleeping disorders, pain, disease activity and damage) showed significantly more fatigue (p < 0.01). In our gradual regression analysis, reduced social activities exhibited the highest correlation with fatigue (Beta 0.535). Overall, in 71.4 % of our SLE patients, we could identify at least one potentially reversible association for fatigue (shown in table 1).

Conclusion: We observed a high prevalence of depressive disorders in our cohort and a significant correlation of depressive status with fatigue. Therefore, we suggest that psychological wellbeing is assessed in everyday clinical practice and treating physicians should react to patients’ needs accordingly. Additionally, obesity, anaemia, hypothyroidism and vitamin D deficiency can easily be assessed. Optimizing these factors represent possible targets in order to improve fatigue in SLE patients.


Table1

Table 1: Potentially reversible associations with fatigue in our cohort of 234 SLE patients, absolute numbers and percentages


Disclosure: C. Duesing, None; G. Chehab, None; J. Richter, None; O. Sander, None; R. Fischer-Betz, None; B. Ostendorf, None; H. Acar, None; R. Brinks, None; M. Schneider, None.

To cite this abstract in AMA style:

Duesing C, Chehab G, Richter J, Sander O, Fischer-Betz R, Ostendorf B, Acar H, Brinks R, Schneider M. Potentially Reversible Associations with Fatigue in SLE Patients – Results from a Single-centre Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/potentially-reversible-associations-with-fatigue-in-sle-patients-results-from-a-single-centre-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/potentially-reversible-associations-with-fatigue-in-sle-patients-results-from-a-single-centre-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology